Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Senn Chemicals specializes in custom manufacturing of peptides, amino acid derivatives, and related compounds for pharmaceutical, biotech, diagnostic, cosmetic, and theragnostic industries. The company operates as a CDMO with cGMP-certified facilities supporting projects from R&D through commercial scale. In April 2025 it was acquired by Granules to expand into the fast-growing peptide therapeutics market—especially GLP‑1-based anti-diabetic/obesity drugs—leveraging its expertise in LPPS/SPPS technologies. No proprietary clinical results or internal drug pipeline have been disclosed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Senn Chemicals.